Mitsubishi Phase 3 Clinical Trial for MT-7117 NEW SITES!

Interested in learning more? The American Porphyria Foundation will share details of the study and connect EPP and XLP patients (Ages 12-75) with a study site for the Mitsubishi Phase 3 clinical trial for MT-7117.

New study site locations at Porphyria Centers have recently been added, including:  

1. University of Texas Medical Branch (Dr. K. Anderson) - Galveston, Texas
2. The University of Miami (Dr. C. Levy) - Miami, Florida
3. Mount Sinai (Dr. M. Balwani) - New York, NY
4. Thomas Jefferson - Dr. Thapar - Philadelphia, PA

Patients can also participate at the following study sites:

1. Wake Forest Baptist (Dr. H. Bonkovsky) - Winston Salem, NC
2. Kansas City, MO (Dr. B. Freilich)

If you are interested in learning more, please contact Edrin Williams, Director of Patient Services; he will connect you with a research coordinator. 

Phone: 301-312-8741 E-mail: edrinw@porphyriafoundation.org